<DOC>
	<DOCNO>NCT00067314</DOCNO>
	<brief_summary>This international study study metastatic breast cancer respond investigational drug treatment , side effect investigational drug give woman metastatic breast cancer often side effect occur . The study also analyze fast investigational drug breakdown product clear blood patient .</brief_summary>
	<brief_title>Study Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline Taxane Therapy</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Taxane</mesh_term>
	<criteria>Locally advanced metastatic breast cancer amenable surgery radiation curative intent Must receive chemotherapy regimen past Evidence tumor resistance last chemotherapy define progression 6 month previous chemotherapy advance disease Must measurable ( image technique ) disease Adequate bone marrow , liver renal function Must provide evidence informed consent willingness ability comply schedule visit , treatment plan study procedure . Received 2 prior chemotherapy regimens metastatic disease Received past another drug class investigational drug , i.e . topoisomerase I inhibitor Enrolled another clinical intervention study Pregnancy , breast feeding , fertile woman refuse use reliable contraceptive method Cardiac thrombotic event last 12 month Brain metastasis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>